A group of 100 federal lawmakers is urging the Biden administration to use controversial provisions of federal law to lower prescription drug prices, and also asked the Department of Health and Human Services Secretary Xavier Becerra for a meeting to discuss the issue.
In a letter to Becerra, the lawmakers reiterated calls for the administration to invoke either march-in rights or another federal law known as Section 1498. Both approaches allow the federal government to sidestep patents and have been championed by academics and advocacy groups, but the administration has not pursued either tactic amid pushback from the pharmaceutical industry.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
